87 related articles for article (PubMed ID: 35982128)
1. Cytidine deaminase activity increases in the blood of breast cancer patients.
Buhagiar-Labarchède G; Onclercq-Delic R; Vacher S; Berger F; Bièche I; Stoppa-Lyonnet D; Amor-Guéret M
Sci Rep; 2022 Aug; 12(1):14062. PubMed ID: 35982128
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?
Frances A; Cordelier P
Mol Ther; 2020 Feb; 28(2):357-366. PubMed ID: 31870623
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
Hong KU; Tagnedji AH; Doll MA; Walls KM; Hein DW
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5047-5060. PubMed ID: 36329350
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Cytidine Deaminase to Thymidylate Biosynthesis in Trypanosoma brucei: Intracellular Localization and Properties of the Enzyme.
Moro-Bulnes A; Castillo-Acosta VM; Valente M; Carrero-Lérida J; Pérez-Moreno G; Ruiz-Pérez LM; González-Pacanowska D
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391279
[TBL] [Abstract][Full Text] [Related]
5. Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patients.
Abbaspour A; Dehghani M; Setayesh M; Tavakkoli M; Rostamipour HA; Ghorbani M; Ramzi M; Omidvari S; Moosavi F; Firuzi O
Cancer Chemother Pharmacol; 2023 Dec; 92(6):475-483. PubMed ID: 37668680
[TBL] [Abstract][Full Text] [Related]
6. Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.
Giovannetti E; Laan AC; Vasile E; Tibaldi C; Nannizzi S; Ricciardi S; Falcone A; Danesi R; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):720-5. PubMed ID: 18600531
[TBL] [Abstract][Full Text] [Related]
7. Loss of cytidine deaminase expression as a potential attempt to counteract the process of carcinogenesis by reducing basal PARP-1 activity and increasing tau levels.
Amor-Guéret M
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167213. PubMed ID: 38714266
[TBL] [Abstract][Full Text] [Related]
8. Cytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumors.
Onclercq-Delic R; Buhagiar-Labarchède G; Leboucher S; Larcher T; Ledevin M; Machon C; Guitton J; Amor-Guéret M
Cancer Lett; 2023 Feb; 555():216030. PubMed ID: 36496104
[TBL] [Abstract][Full Text] [Related]
9. Selection of the best blood compartment to measure cytidine deaminase activity to stratify for optimal gemcitabine or cytarabine treatment.
Peters GJ; Honeywell RJ; Maulandi M; Giovannetti E; Losekoot N; Etienne-Grimaldi MC; Milano G; Serdjebi C; Ciccolini J;
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):403-12. PubMed ID: 24940698
[TBL] [Abstract][Full Text] [Related]
10. High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine.
Raynal C; Ciccolini J; Mercier C; Boyer JC; Polge A; Lallemant B; Mouzat K; Lumbroso S; Brouillet JP; Evrard A
Ther Drug Monit; 2010 Feb; 32(1):53-60. PubMed ID: 20010457
[TBL] [Abstract][Full Text] [Related]
11. Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies.
Ciccolini J; Dahan L; André N; Evrard A; Duluc M; Blesius A; Yang C; Giacometti S; Brunet C; Raynal C; Ortiz A; Frances N; Iliadis A; Duffaud F; Seitz JF; Mercier C
J Clin Oncol; 2010 Jan; 28(1):160-5. PubMed ID: 19933910
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and structural analysis of the Klebsiella pneumoniae cytidine deaminase CDA.
Liu W; Shang F; Chen Y; Lan J; Wang L; Chen J; Gao P; Ha NC; Quan C; Nam KH; Xu Y
Biochem Biophys Res Commun; 2019 Nov; 519(2):280-286. PubMed ID: 31495495
[TBL] [Abstract][Full Text] [Related]
13. Cytidine deaminase enables Toll-like receptor 8 activation by cytidine or its analogs.
Furusho K; Shibata T; Sato R; Fukui R; Motoi Y; Zhang Y; Saitoh SI; Ichinohe T; Moriyama M; Nakamura S; Miyake K
Int Immunol; 2019 Mar; 31(3):167-173. PubMed ID: 30535046
[TBL] [Abstract][Full Text] [Related]
14. Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo.
Yoshida T; Endo Y; Obata T; Kosugi Y; Sakamoto K; Sasaki T
Drug Metab Dispos; 2010 Oct; 38(10):1814-9. PubMed ID: 20587622
[TBL] [Abstract][Full Text] [Related]
15. Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs.
Serdjebi C; Milano G; Ciccolini J
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):665-72. PubMed ID: 25495470
[TBL] [Abstract][Full Text] [Related]
16. Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.
Lumeau A; Bery N; Francès A; Gayral M; Labrousse G; Ribeyre C; Lopez C; Nevot A; El Kaoutari A; Hanoun N; Sarot E; Perrier M; Pont F; Cerapio JP; Fournié JJ; Lopez F; Madrid-Mencia M; Pancaldi V; Pillaire MJ; Bergoglio V; Torrisani J; Dusetti N; Hoffmann JS; Buscail L; Lutzmann M; Cordelier P
Cancer Res; 2024 Apr; 84(7):1013-1028. PubMed ID: 38294491
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporin on the activity of cytidine deaminase and adenosine deaminase in the serum and polymorphonuclear leukocytes of patients with rheumatoid arthritis.
Stancíková M; Rovenský J
Int J Tissue React; 1993; 15(4):169-74. PubMed ID: 8188457
[TBL] [Abstract][Full Text] [Related]
18. A decrease in NAMPT activity impairs basal PARP-1 activity in cytidine deaminase deficient-cells, independently of NAD
Silveira SC; Buhagiar-Labarchède G; Onclercq-Delic R; Gemble S; Bou Samra E; Mameri H; Duchambon P; Machon C; Guitton J; Amor-Guéret M
Sci Rep; 2020 Aug; 10(1):13907. PubMed ID: 32807821
[TBL] [Abstract][Full Text] [Related]
19. Association of Cytidine Deaminase Polymorphism with Capecitabine Effectiveness in Breast Cancer Patients.
Aldeen Majeed AA; Salih Sahib A; Shakir Mahmood H; Kadhim Mohsin K; Fadhl Abbas R
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4219-4225. PubMed ID: 38156857
[TBL] [Abstract][Full Text] [Related]
20. Site directed mutagenesis as a tool to understand the catalytic mechanism of human cytidine deaminase.
Vincenzetti S; Pucciarelli S; Carpi FM; Micozzi D; Polzonetti V; Natalini P; Santarelli I; Polidori P; Vita A
Protein Pept Lett; 2013 May; 20(5):538-49. PubMed ID: 23033855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
